Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Gynaecology
  4. Back
  5. Gynaecology guidelines
  6. Management of suspicious cervix in pregnancy, Gynaecology (1091)
Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. 

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.  To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Management of suspicious cervix in pregnancy, Gynaecology (1091)

Warning

Objectives

To define the management of women who are pregnant and are found to have a concerning cervical appearance during speculum examination

Scope

To be applied to women who are pregnant and are found to have an abnormality of their cervix.

Audience

All healthcare professionals in Greater Glasgow and Clyde including midwives, doctors and nurses involved in the care of pregnant women where a cervical abnormality has been identified.

Please report any inaccuracies or issues with this guideline using our online form

Within pregnancy, speculum examinations are generally performed after a patient present with symptoms such as abnormal vaginal discharge, vaginal bleeding, pre-term labour or rupture of membranes.

History

Before the examination consider the following which can be determined by history taking.

  • Is infection suspected?
  • Has the patient had any previous treatment to her cervix?
  • Is there a history of abnormal smears?
  • Has she been sexually active recently?
  • Does she have a cervical suture or vaginal pessary in place?
  • Is she using vaginal pessaries which may change her vaginal discharge e.g. vaginal progesterone?
  • Is there a history consistent with early labour including rupture of membranes?

If cervical screening history is uncertain and the patient is ≥25 years of age, the national Scottish Cervical Call Recall System database (SCCRS) may contain relevant information.

Opportunistic cervical smears should not be taken during pregnancy within the Obstetric Department.

Diagnosis

If concerns regarding cervical appearance, it is important to describe and document the size, number, consistency and origin of any cervical lesions, along with any contact bleeding.

If any concern over appearance of cervix at examination, confirmation should be made by the on call Consultant or senior trainee (ST6/7) in the first instance.

If a vaginal infection is suspected, high vaginal swabs should be taken and consideration of STI screen.  These may include Chlamydia/Gonorrhoea nucleic acid amplification tests (NAAT) vulvovaginal swab or lesion swab for PCR medium e.g. for herpes.

Patients presenting with vaginal bleeding should be managed in line with current guidelines for Antepartum Haemorrhage or Vaginal bleeding in <24 weeks. (see relevant guidelines for gestation)

Cervical appearance during pregnancy

The appearance of the cervix can change in normal pregnancy. Features can include an increase in cervical size, a bluish appearance due to increase vascularity.  These physiological changes may appear suspicious to an inexperienced clinician (2).

Most cervical abnormalities are benign and patients can be reassured and managed conservatively.  Some changes are described below.

  • Cervical ectopy – most common benign abnormality and may be associated with increased physiological discharge, no further investigation required.
  • Nabothian Follicles/Cysts – normal finding in women of childbearing age
  • Cervicitis/inflammation of the cervix – this can be acute or chronic and are most likely associated with Sexually Transmitted Infections (HSV, chlamydia, gonnorrhoea, trichomonas). Screening with appropriate swabs should be undertaken.
  • Condyloma (genital warts) - may be present in remainder of genital tract including vagina and vulva.

Cervical Polyp –They can be found in up to 4% of women, and are commonly asymptomatic.  However, in pregnancy they may present with vaginal bleeding or antepartum haemorrhage. They can be ectocervical, endocervical or endometrial in origin.

Risk of malignancy is low estimated at <0.1% in the pre-menopausal woman (3).  If there is clinical concern that the polyp may be atypical and/or previous unresolved abnormal cervical cytology, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted.  This should be an urgently dictated letter, which is sent to colposcopy via Scottish Care Information gateway (SCI-gateway) referral pathway by the transcribing secretary.

All patients with cervical polyps, irrespective of antenatal management should be reviewed in postnatally (obstetrics or general gynaecology) at 6-12 weeks. This should be highlighted via Alert tab in Badger, and referral made using a dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.

Suspicious cervical mass - cervical carcinoma is rare in pregnancy with estimated prevalence 1-10/10 000 pregnancies (2). 

If malignancy is suspected on clinical examination in a stable patient, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted.  This should be an urgently dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.

Colposcopy

Referral to colposcopy should be made by senior trainee (ST6/7)/consultant by written referral including summary of pregnancy.  This should be an urgently dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.  It is useful to copy in the patient’s named Obstetrician and their own GP.

Referral should contain:

  • Patient’s named Obstetrician and contact details (may be useful to include their secretary as a contact point)
  • Presenting symptoms
  • Clinical findings indicating referral
  • Investigations undertaken e.g. swabs
  • Placental site
  • Any issues with pregnancy

Clinical assessment of the cervix will be undertaken and outcome of this examination will be shared with patient’s named consultant Obstetrician and referring clinician.

Unless the suspicion of malignancy is high at colposcopy, it is most likely that a conservative approach will be adopted.  Any further follow-up will be arranged by the colposcopist postnatally.

If a biopsy during pregnancy if felt to be warranted, this will generally be undertaken by an experienced colposcopist in a theatre setting after planning with the obstetric team. This is due to the associated increase in haemorrhage and complications.

Editorial Information

Last reviewed: 14/06/2023

Next review date: 31/05/2028

Author(s): Dr Victoria Flannigan, Consultant O&G, Dr Sandra Wong, Consultant O&G.

Approved By: Gynaecology Clinical Governance Group

Document Id: 1091

References
  1. Panayotidis, Costas & Cilly, Latika. (2013). Cervical Polypectomy during Pregnancy: The Gynaecological Perspective. J Genit Syst Disor. 2. 10.4172/2325-9728.1000108.
  2. China S, Sinha Y, Sinha D, Hillaby K. Management of gynaecological cancer in pregnancy.The Obstetrician & Gynaecologist2017;19:139–46. DOI: 10.1111/tog.1236
  3. Nelson AL, Papa RR, Ritchie JJ. Asymptomatic Cervical Polyps: Can We Just Let them Be? Women’s Health. March 2015:121-126. doi:10.2217/WHE.14.86